Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07282080

Discover Better Body Composition With Green Light!

Investigation into Green Light Therapy study using EmeraldLED for 15-minute sessions, twice a week, to support positive changes in body composition.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

This remotely administered decentralized trial is designed to rigorously explore the efficacy of green light therapy in influencing body composition and overall well-being. Under the leadership of Ryan, CEO of beem® Light Sauna, this study leverages the expansive network of over 50 wellness franchise locations across the United States, along with 30 years of fitness and wellness industry experience, to investigate the science-backed potential of green light therapy. Amidst the widespread speculation and anecdotal evidence circulating on social media, investigators seek to provide concrete, personalized data to participants, thereby empowering them with the knowledge to make informed decisions about their health and wellness strategies.

The core objective of this online study is to empower participants by providing a detailed analysis of how exposure to green light impacts their weight management journey and overall sense of well-being. By participating in this study, individuals will receive tailored feedback on their body composition changes and psychological well-being, offering a unique opportunity to understand the potential benefits of green light therapy on a personal level.

Participants in this remotely conducted trial will engage with state-of-the-art green light therapy sessions from the comfort of their chosen environment, ensuring a broad and inclusive participant base without geographic limitations. This approach not only facilitates a more diverse data set but also aligns with our commitment to making health innovations accessible to a wider audience.

The significance of this study cannot be overstated, as it aims to demystify the claims surrounding green light therapy and its effects on weight management and mental health. By contributing to this pioneering research, participants will be at the forefront of a potential paradigm shift in the approach to wellness and body composition optimization. While acknowledging the limitations of this study and the need for further extensive trials, the insights gained here will be invaluable in guiding future health innovations and strategies, marking a significant step towards a healthier, more informed society.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Can read and understand English.
  • US resident.
  • Willing and able to follow the requirements of the protocol.

Exclusion criteria

-individuals with eye conditions

Treatment and study plan

EmeraldLED

Device

This device is a customizable, multi-wavelength therapeutic system designed for individualized cosmetic treatments. It features an easy-to-use interface with preprogrammed treatment categories, a wide pulsing frequency range from 1 to 15,000 Hz, and independent wavelength control for precise protocol tailoring. The system delivers five wavelengths-450 nm, 525 nm, 650 nm, 810 nm, and 980 nm-with an output power of 3,325 W and irradiance up to 119 mW/cm².

The green light EmeraldLED therapy provided in this study is set at 525 nm.

Primary outcomes

  1. Body Image and Self-Perception Survey

    Time frame: Change from baseline (Day 1-3) in body image and self-perception at 4 weeks after the start of the intervention (Day 27-33)

    This survey aims to understand an individual's perception of their body, attractiveness, and physical functionality. It contains multiple-choice questions with five options ranging from 'Strongly Disagree' to 'Strongly Agree'. The questions are divided into three categories: Body Satisfaction, Attractiveness Evaluation, and Physical Functionality Awareness.

  2. Body Composition Measurement Form

    Time frame: Change from baseline (Day 1-3) in body composition measurements at 4 weeks after the start of the intervention (Day 27-33)

    The Body Composition Measurement Form is specifically crafted to accurately track changes in body measurements relevant to individuals engaged in weight loss or bodybuilding. This form allows for the consistent recording of key physical metrics across various body parts, facilitating the evaluation of fitness progress. By using this form, individuals can obtain a clear picture of the physical changes resulting from their exercise routines and nutritional choices. Each measurement is to be recorded in centimeters to maintain uniformity and precision.

  3. Quality of Life and Health Survey

    Time frame: Change from baseline (Day 1-3) in quality of life and health perceptions at 4 weeks after the start of the intervention (Day 27-33)

    This survey asks about your feelings towards your quality of life, health, and various areas of your life. It covers your experiences and feelings in the past four weeks. Please choose the answer that appears most appropriate.

Study contacts

Contact information is provided by the study sponsor or research team.

Matthew Amsden

CONTACT

[email protected]

646-679-2479

Sponsors and collaborators

Lead sponsor

Efforia, Inc

Industry

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 15, 2025
Registry last updated
Dec 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.